Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024
Go back to Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024| (NASDAQ: SPRB) | Delayed: 43.37 +1.92 (4.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.45 | 52 Week High | $ | |||
| Open | $41.99 | 52 Week Low | $ | |||
| Day High | $43.49 | P/E | N/A | |||
| Day Low | $41.99 | EPS | $ | |||
| Volume | 59,130 | |||||

